南模生物: 关于股东及其一致行动人权益变动触及5%整数倍的提示性公告

Core Viewpoint - The announcement details a change in shareholding for Shanghai Nanmo Biological Technology Co., Ltd., indicating an increase in shares held by Shanghai Pudong New Industry Investment Co., Ltd. and its concerted action party, without triggering a mandatory takeover or changing the controlling shareholder [1][2]. Summary by Sections Shareholding Changes - Prior to the change, Shanghai Pudong New Industry held 2,160,000 shares, representing 2.77% of the total share capital, while its concerted action party, Suzhou Haiwang Hezong No.1 Equity Investment Partnership, held 8,679,727 shares, or 11.13%. Together, they held 10,839,727 shares, accounting for 13.90% of the total [1][3]. - On July 16, 2025, Pudong New Industry increased its holdings by 854,800 shares, bringing its total to 3,014,800 shares, or 3.87%. The combined holdings of Pudong New Industry and Haiwang Hezong now total 11,694,527 shares, or 15.00%, reaching a 5% integer multiple [2][3]. Funding Source - The funds used for the share increase by Pudong New Industry were sourced entirely from its own capital, confirming the legality of the funding [4]. Compliance and Regulatory Notes - The share transfer of 8,679,727 shares by Haiwang Hezong is pending compliance confirmation from the Shanghai Stock Exchange and must complete the transfer registration with the China Securities Depository and Clearing Corporation [2][3].